IP Library › Granted Patent US 12,226,609
Granted Patent B2
US 12,226,609 · App. 17/247,561 · Granted Feb 18, 2025

Method to detect inadvertent delivery of drug to a subcutaneous pocket

Inventor: Jeffrey P. Bodner (Plymouth, MN)
Assignee: Medtronic, Inc.
A61M5/14276A61M5/16809A61M2205/02A61M2205/3324A61M2205/3368A61M2205/3553
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,609
App. No.
17/247,561
Granted
Feb 18, 2025
Kind
B2
Abstract

An implantable medical device configured to monitor fluid in proximity to an implantable medical device for an inadvertent introduction of infusate into a pocket of tissue surrounding the implantable medical device during a refill procedure, the implantable medical device including a refillable infusate delivery system, the refillable infusate delivery system including a reservoir in fluid communication with an access port, and a conductivity sensor configured to monitor fluid in proximity to the conductivity sensor for an introduction of infusate into a pocket of tissue surrounding the implantable medical device, wherein the conductivity sensor comprises a pair of electrodes positioned on an external surface of the implantable medical device.

Claims (31)

1. An implantable medical device, comprising:

a refillable infusate delivery system, the refillable infusate delivery system comprising a reservoir in fluid communication with an access port;

two or more exterior sensors positioned on an external surface of the implantable medical device and configured to monitor fluid in proximity to an exterior of the implantable medical device for an injection of infusate into a pocket of tissue surrounding the implantable medical device during a procedure to refill the reservoir with infusate when the reservoir is empty; and

a processor configured to monitor the two or more exterior sensors during infusate refill procedures and to activate one or more notification, alert or alarm features to notify a user that a pocket fill may be occurring.

2. The implantable medical device of claim 1 , wherein the two or more exterior sensors comprise at least one of one or more electrodes, one or more pH sensors, one or more temperature sensors, or a combination thereof.

3. The implantable medical device of claim 1 , wherein the two or more exterior sensors comprise a pair of electrodes constructed of a platinum iridium material positioned on the exterior of the implantable medical device.

4. The implantable medical device of claim 1 , wherein the two or more exterior sensors comprise at least one electrode having a diameter of between about 1 mm and about 3 mm.

5. The implantable medical device of claim 1 , wherein the two or more exterior sensors comprise an electrode at least partially surrounded by an insulative material to insulate the electrode from a metallic external surface of the implantable medical device.

6. The implantable medical device of claim 1 , wherein the two or more exterior sensors comprise a first sensor positioned on a first surface of the implantable medical device, and a second sensor positioned on a second surface of the implantable medical device.

7. The implantable medical device of claim 1 , wherein the implantable medical device is at least one of an implantable infusion pump or an implantable port.

8. The implantable medical device of claim 1 , wherein the implantable medical device further comprises at least one of an access port marker to improve identification of the access port, a needle detector to confirm proper placement of a refilling apparatus within the access port, and a reservoir fill sensor to aid in positioning of a refilling device relative to the implantable medical device.

9. The implantable medical device of claim 1 , further comprising a physiological sensor configured to provide a confirmation of an introduction of infusate into a pocket of tissue surrounding the implantable medical device through a monitoring of one or more physiological conditions of a patient into which the implantable medical device is implanted.

10. A medical system, comprising:

an implantable medical device comprising an infusate delivery system; two or more exterior sensors positioned on an external surface of the implantable medical device and configured to monitor fluid in proximity to an exterior of the implantable medical device for an injection of infusate into a pocket of tissue surrounding the implantable medical device during a procedure to refill the device with infusate when the device is empty; and a processor configured to monitor the two or more exterior sensors during infusate refill procedures and to activate one or more notification, alert or alarm features to notify a user that a pocket fill may be occurring.

11. The medical system of claim 10 , wherein the two or more exterior sensors comprise at least one of one or more electrodes, one or more pH sensors, one or more temperature sensors, or a combination thereof.

12. The medical system of claim 10 , wherein the implantable medical device is at least one of an implantable infusion pump or an implantable port.

13. The medical system of claim 10 , wherein the two or more exterior sensors comprise a first sensor positioned on a first surface of the implantable medical device, and a second sensor positioned on a second surface of the implantable medical device, the first and second surface being exterior of the implantable medical device.

14. The medical system of claim 10 , wherein the implantable medical device further comprises at least one of an access port marker to improve identification of an access port of the implantable medical device, a needle detector to confirm proper placement of a refilling apparatus within an access port of the implantable medical device, and a reservoir fill sensor to aid in positioning of a refilling device relative to the implantable medical device.

15. The medical system of claim 10 , further comprising a physiological sensor configured to provide a confirmation of an introduction of infusate into a pocket of tissue surrounding the implantable medical device through a monitoring of one or more physiological conditions of a patient into which the implantable medical device is implanted.

16. The medical system of claim 10 , further comprising an external programmer in wireless communication with the implantable medical device.

17. The medical system of claim 16 , wherein the external programmer is configured to activate the two or more exterior sensors from an inactive state.

18. The medical system of claim 10 , further comprising an external physiological sensor in wireless communication with at least one of the external programmer or implantable medical device, the external physiological sensor configured to provide a confirmation of an introduction of infusate into a pocket of tissue surrounding the implantable medical device through a monitoring of one or more physiological conditions of a patient into which the implantable medical device is implanted.

19. A method of monitoring fluid in proximity to an implantable medical device for an inadvertent injection of infusate into a pocket of tissue surrounding the implantable medical device during an infusate refill procedure, the method comprising:

activating two or more exterior sensors positioned on an external surface of the implantable medical device and configured to monitor fluid in proximity to an exterior of the implantable medical device;

obtaining a baseline measurement;

establishing a triggering threshold value; and

initiating at least one of an alarm, alert or notification upon a measurement sensed by the two or more exterior sensors meeting or exceeding the triggering threshold value.

20. The method of claim 19 , wherein the two or more exterior sensors comprise at least one of one or more electrodes, one or more pH sensors, one or more temperature sensors, or a combination thereof.

21. The method of claim 19 , wherein the two or more exterior sensors are activated via an external programmer upon initiation of a refill procedure.

22. The method of claim 19 , further comprising activating at least one of an access port marker to improve identification of the access port, a needle detector to confirm proper placement of a refilling apparatus within the access port, and a reservoir fill sensor to aid in positioning of a refilling device relative to the implantable medical device.

23. The method of claim 19 , further comprising monitoring a physiological sensor, the physiological sensor configured to provide a confirmation of an introduction of infusate into a pocket of tissue surrounding the implantable medical device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2020
From: BODNER, JEFFREY P.
To: MEDTRONIC, INC.
Reel/Frame 054790/0517 →
Continuity (1)
Related Publication 20220184298A1 · Jun 16, 2022
References Cited (93)
US 4360019A · Portner et al. · 1982 [cited by applicant]
US 4573994A · Fischell et al. · 1986 [cited by applicant]
US 4772263A · Dorman et al. · 1988 [cited by applicant]
US 5045064A · Idriss · 1991 [cited by applicant]
US 5085644A · Watson et al. · 1992 [cited by applicant]
US 5217442A · Davis · 1993 [cited by applicant]
US 5281210A · Burke et al. · 1994 [cited by applicant]
US 5527307A · Srisathapat et al. · 1996 [cited by applicant]
US 5702372A · Nelson · 1997 [cited by applicant]
US 5833654A · Powers et al. · 1998 [cited by applicant]
US 5957890A · Mann et al. · 1999 [cited by applicant]
US 6013051A · Nelson · 2000 [cited by applicant]
US 6042579A · Elsberry et al. · 2000 [cited by applicant]
US 6283943B1 · Dy et al. · 2001 [cited by applicant]
US 6572583B1 · Olsen et al. · 2003 [cited by applicant]
US 6579280B1 · Kovach et al. · 2003 [cited by applicant]
US 6852106B2 · Watson et al. · 2005 [cited by applicant]
US 6962577B2 · Tallarida et al. · 2005 [cited by applicant]
US 6962580B2 · Adams et al. · 2005 [cited by applicant]
US 7072802B2 · Hartlaub · 2006 [cited by applicant]
US 7351239B2 · Gill · 2008 [cited by applicant]
US 7366562B2 · Dukesherer et al. · 2008 [cited by applicant]
US 7637897B2 · Ginggen · 2009 [cited by applicant]
US 7803143B2 · Tallarida et al. · 2010 [cited by applicant]
US 7942863B2 · Kalpin et al. · 2011 [cited by applicant]
US 7963956B2 · Kunst · 2011 [cited by applicant]
US 8320991B2 · Jascob et al. · 2012 [cited by applicant]
US 8419710B2 · Keimel et al. · 2013 [cited by applicant]
US 8483802B2 · Kalpin et al. · 2013 [cited by applicant]
US 8545484B2 · Haase et al. · 2013 [cited by applicant]
US 8591456B2 · Steinbach · 2013 [cited by applicant]
US 8613724B2 · Lanier, Jr. et al. · 2013 [cited by applicant]
US 8721605B2 · Brandt et al. · 2014 [cited by applicant]
US 8915893B2 · Steinbach · 2014 [cited by applicant]
US 8932271B2 · Hamatake et al. · 2015 [cited by applicant]
US 9079004B2 · Wiley et al. · 2015 [cited by applicant]
US 9122785B2 · Alme et al. · 2015 [cited by applicant]
US 9421325B2 · Kalpin · 2016 [cited by applicant]
US 9427553B2 · Nelson · 2016 [cited by applicant]
US 9433764B2 · East et al. · 2016 [cited by applicant]
US 9744338B2 · East et al. · 2017 [cited by applicant]
US 9782536B2 · Skutnik et al. · 2017 [cited by applicant]
US 9919102B2 · John · 2018 [cited by applicant]
US 9981117B2 · Brandt et al. · 2018 [cited by applicant]
US 9993600B2 · Lanier, Jr. et al. · 2018 [cited by applicant]
US 10238851B2 · Butziger et al. · 2019 [cited by applicant]
US 10376635B2 · Haase · 2019 [cited by applicant]
US 10589024B2 · John · 2020 [cited by applicant]
US 10596362B2 · Fielder et al. · 2020 [cited by applicant]
US 10625060B2 · Børgesen · 2020 [cited by applicant]
US 11147918B2 · Christensen · 2021 [cited by applicant]
US 20050124980A1 · Sanders · 2005 [cited by applicant]
US 20050137537A1 · Watson et al. · 2005 [cited by applicant]
US 20050277912A1 · John · 2005 [cited by examiner]
US 20060089619A1 · Ginggen · 2006 [cited by applicant]
US 20060089620A1 · Gibson · 2006 [cited by applicant]
US 20070078391A1 · Wortley · 2007 [cited by examiner]
US 20070112291A1 · Børgesen · 2007 [cited by applicant]
US 20080243074A1 · Miesel · 2008 [cited by examiner]
US 20080243093A1 · Kalpin et al. · 2008 [cited by applicant]
US 20090192404A1 · Ortiz · 2009 [cited by examiner]
US 20100030196A1 · Hildebrand et al. · 2010 [cited by applicant]
US 20110301575A1 · Miesel et al. · 2011 [cited by applicant]
US 20120053514A1 · Robinson et al. · 2012 [cited by applicant]
US 20130116665A1 · Humayun · 2013 [cited by examiner]
US 20140228765A1 · Burke et al. · 2014 [cited by applicant]
US 20160089521A1 · Dragoon et al. · 2016 [cited by applicant]
US 20160354540A1 · Kalpin · 2016 [cited by applicant]
US 20170043151A1 · Bellrichard et al. · 2017 [cited by applicant]
US 20170325685A1 · Shachar et al. · 2017 [cited by applicant]
US 20180117243A1 · Maguire · 2018 [cited by applicant]
US 20190009014A1 · Chen et al. · 2019 [cited by applicant]
US 20190060565A1 · Gyory · 2019 [cited by applicant]
US 20190184139A1 · Nelson et al. · 2019 [cited by applicant]
US 20190269850A1 · Shih et al. · 2019 [cited by applicant]
US 20200061362A1 · Singh et al. · 2020 [cited by applicant]
US 20200121849A1 · Christensen · 2020 [cited by applicant]
US 20200121850A1 · Christensen · 2020 [cited by applicant]
US 20200155003A1 · Mitchell · 2020 [cited by examiner]
CN 208838708U · 2019 [cited by applicant]
ES 2267396A1 · 2007 [cited by examiner]
WO WO0066204A1 · 2000 [cited by applicant]
WO WO2009129474A1 · 2009 [cited by applicant]
WO WO2012138854A1 · 2012 [cited by applicant]
WO WO2013052414 · 2013 [cited by applicant]
WO WO2013134486A4 · 2013 [cited by applicant]
WO WO2016059162A1 · 2016 [cited by applicant]
WO WO2020046791A1 · 2020 [cited by applicant]
Extended European Search Report for European Application No. 19202531.0, dated Jan. 27, 2020. [cited by applicant]
Alcyone Lifesciences, Inc., Bringing Hope to Spinal Muscular Atrophy (SMA) Patients with the Alcyone Lifesciences ThecaFlex DRx™ System Breakthrough Device, Dec. 2, 2019, 3 pages, available at: https://www.prnewswire.co… [cited by applicant]
Application and File history for U.S. Appl. No. 16/168,358, filed Oct. 23, 2018. Inventors: Christenson et al. [cited by applicant]
Application and File history for U.S. Appl. No. 16/168,399, filed Oct. 23, 2018. Inventors: Christenson et al. [cited by applicant]
Application and File history for U.S. Appl. No. 17/085,562, filed Oct. 30, 2020. Inventors: Bodner. [cited by applicant]